NCT04087746View on ClinicalTrials.gov

Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME)

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

June 30, 2019

Conditions
Diabetic Macular Edema
Interventions
DRUG

Aflibercept

Intra-vitreal injection of AVEGF AFLIBERCEPT in group I

DRUG

Ranibizumab

Intra-vitreal injection of AVEGF Ranibizumab in group 2

Trial Locations (1)

Unknown

Minia University, Minya

All Listed Sponsors
lead

Minia University

OTHER

NCT04087746 - Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) | Biotech Hunter | Biotech Hunter